Integra LifeSciences Holdings Corp. (IART)
11.91
-0.42
(-3.37%)
USD |
NASDAQ |
Oct 23, 16:00
11.90
-0.01
(-0.08%)
After-Hours: 20:00
Integra LifeSciences Holdings Total Assets (Quarterly) : 3.508B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 3.508B |
| June 30, 2026 | 3.563B |
| March 31, 2026 | 3.578B |
| December 31, 2025 | 3.602B |
| September 30, 2025 | 3.646B |
| June 30, 2025 | 3.668B |
| March 31, 2025 | 4.053B |
| December 31, 2024 | 4.037B |
| September 30, 2024 | 4.066B |
| June 30, 2024 | 4.074B |
| March 31, 2024 | 4.078B |
| December 31, 2023 | 3.782B |
| September 30, 2023 | 3.739B |
| June 30, 2023 | 3.778B |
| March 31, 2023 | 3.742B |
| December 31, 2022 | 3.890B |
| September 30, 2022 | 3.807B |
| June 30, 2022 | 3.753B |
| March 31, 2022 | 3.672B |
| December 31, 2021 | 3.782B |
| September 30, 2021 | 3.774B |
| June 30, 2021 | 3.713B |
| March 31, 2021 | 3.742B |
| December 31, 2020 | 3.615B |
| September 30, 2020 | 3.454B |
| Date | Value |
|---|---|
| June 30, 2020 | 3.392B |
| March 31, 2020 | 3.448B |
| December 31, 2019 | 3.303B |
| September 30, 2019 | 3.347B |
| June 30, 2019 | 3.290B |
| March 31, 2019 | 3.206B |
| December 31, 2018 | 3.108B |
| September 30, 2018 | 3.179B |
| June 30, 2018 | 3.186B |
| March 31, 2018 | 3.248B |
| December 31, 2017 | 3.211B |
| September 30, 2017 | 2.418B |
| June 30, 2017 | 2.101B |
| March 31, 2017 | 2.049B |
| December 31, 2016 | 1.808B |
| September 30, 2016 | 1.827B |
| June 30, 2016 | 1.814B |
| March 31, 2016 | 1.830B |
| December 31, 2015 | 1.775B |
| September 30, 2015 | 1.828B |
| June 30, 2015 | 1.638B |
| March 31, 2015 | 1.551B |
| December 31, 2014 | 1.579B |
| September 30, 2014 | 1.546B |
| June 30, 2014 | 1.563B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Penumbra, Inc. | 1.975B |
| Abbott Laboratories | -- |
| Boston Scientific Corp. | 45.22B |
| Globus Medical, Inc. | 5.488B |
| Sight Sciences, Inc. | 104.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.441B |
| Shareholders Equity (Quarterly) | 1.067B |
| Debt to Equity Ratio | 1.877 |
| Current Ratio | 3.617 |
| Net Debt Paydown Yield | 0.18% |